Topical Collection "Benign and Malignant Germ Cell Tumors"
A topical collection in Cancers (ISSN 2072-6694).
Interests: urological tumors; molecular pathology; tumor markers; epigenetics; epitranscriptomics; epi-drugs
Interests: Germ cell tumors, fertility, disorders of sex development; (Molecular) Biomarkers; Treatment sensitivity and resistance
Interests: uropathology; cancer biomarkers; epigenetics
Malignant germ cell tumors (GCTs) are among the most common cancers afflicting young adults. Despite their high curability, incidence is rising as well as disease burden, owing to chemo- and radiotherapy-induced morbidity. Moreover, a restricted, but significant, number of patients develop therapy-resistance, entailing poor prognosis, and the underlying mechanisms are mostly unknown. GCTs are archetypes of morphological heterogeneity, although the genetic background is rather similar. Hence, improved understanding of immunological signatures, molecular pathways and epigenetic alterations underlying the pathology is mandatory. Finally, the limitations of “classical” biomarkers (AFP, betaHCG) have stimulated the search for novel disease biomarkers, allowing for improved disease monitoring and refinement of therapeutic strategies, especially for the most aggressive subtypes.
Thus, in this Special Issue, we aim to cover all relevant aspects of malignant GCT encompassing basic, preclinical, and clinical research in this challenging tumor model.
Prof. Carmen Jerónimo
Prof. Leendert H.J. Looijenga
Prof. Rui Henrique
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the collection website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- similarities and differences between gonadal and extragonadal GCT
- advances in pathological assessment of GCT
- epigenetics and epigenomics of GCT/subtyping/molecular profiling of GCT
- micro-environment and selection
- GCT tumor microenvironment/GCT cancer stem cells
- signaling pathways in GCT
- biomarkers for detection and monitoring of GCT
- GCT tumorigenesis, heterogeneity and metastasis
- preclinical models
- animal models of GCT
- in vitro models of GCT
- clinical aspects
- imaging of GCT
- drug delivery to GCT cells
- molecular targeted therapies for GCT
- precision medicine for GCT
- innovative therapeutic strategies for GCT
Jump to: 2019
Jump to: 2020